Fact CheckerSign in

NCT06829524Recruiting

HANDLE-a Real World Study on Satralizumab in NMOSD

A Real-World Practical Model of Integrated Management for Chinese Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD) on Satralizumab

Source: ClinicalTrials.gov · Last updated 18 Sept 2026

Brief summary (registry, in English)

This study is a single-center, retrospective-prospective, non-interventional cohort study to assess the clinical outcomes of Chinese NMOSD patients treated with satralizumab in a real-world patient management model by collecting follow-up data in clinical practice.

Status (registry)
Recruiting
Study type
Observational
Enrollment
100 (estimated)
First submitted
11 Feb 2025
Start date
31 Mar 2025
Primary completion date
31 Mar 2027
Lead sponsor
Huashan Hospital
NCT number
NCT06829524

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From 31 Mar 2025 to the primary completion date, 31 Mar 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • \-

Who the study is looking for

  • Patients have been diagnosed with NMOSD and tested seropositive for AQP4 antibody, ≥ 12 years old;
  • EDSS score ≤ 8.5 at baseline;
  • Patients have experienced ≥ 1 relapse of NMOSD in the last 12 months or ≥ 2 relapses in the last 24 months;
  • Patients should have received or be anticipated to receive satralizumab treatment for at least 12 months;
  • Patients understand the study procedures and sign the informed consent form indicating willingness to participate in the study (for those \< 18 years of age, the guardian should sign the informed consent form on behalf of the patient).

Age in the registry: 12 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Huashan Hospital
Coordinator of this site? Confirm its status
ShanghaiChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.